Segment Reporting

9 Months Ended

Sep. 30, 2013

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting. We report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases, including our embolotherapeutic products. Our endoscopy segment consists of gastroenterology and pulmonary medical device products which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. We evaluate the performance of our operating segments based on operating income (loss). Financial information relating to our reportable operating segments and reconciliations to the consolidated totals is as follows (in thousands):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2013		2012			2013		2012
Revenues
Cardiovascular	$	110,859	$	92,106		$	316,566	$	280,336
Endoscopy	4,351		3,801			12,467		11,721
Total revenues	115,210		95,907			329,033		292,057
Operating income (loss)
Cardiovascular	7,753		9,169			16,031		26,005
Endoscopy	638		(87		)	897		(694		)
Total operating income	$	8,391	$	9,082		$	16,928	$	25,311